QS Investors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-68,990
| Closed | -$1.78M | – | 1095 |
|
|
2021
Q1 | $1.78M | Buy |
68,990
+55,290
| +404% | +$1.43M | 0.02% | 375 |
|
|
2020
Q4 | $732K | Hold |
13,700
| – | – | 0.01% | 608 |
|
|
2020
Q3 | $566K | Sell |
13,700
-48,700
| -78% | -$2.01M | 0.01% | 633 |
|
|
2020
Q2 | $3.03M | Sell |
62,400
-50
| -0.1% | -$2.42K | 0.04% | 343 |
|
|
2020
Q1 | $2.64M | Buy |
62,450
+100
| +0.2% | +$4.23K | 0.04% | 329 |
|
|
2019
Q4 | $2.56M | Sell |
62,350
-1,500
| -2% | -$61.7K | 0.03% | 509 |
|
|
2019
Q3 | $2.3M | Hold |
63,850
| – | – | 0.03% | 523 |
|
|
2019
Q2 | $1.71M | Sell |
63,850
-139,232
| -69% | -$3.72M | 0.02% | 639 |
|
|
2019
Q1 | $5.45M | Sell |
203,082
-1,553
| -0.8% | -$41.7K | 0.06% | 236 |
|
|
2018
Q4 | $3.31M | Hold |
204,635
| – | – | 0.04% | 345 |
|
|
2018
Q3 | $4.25M | Buy |
204,635
+198,635
| +3,311% | +$4.12M | 0.04% | 331 |
|
|
2018
Q2 | $92K | Buy |
6,000
+4,183
| +230% | +$64.1K | ﹤0.01% | 1426 |
|
|
2018
Q1 | $41K | Hold |
1,817
| – | – | ﹤0.01% | 1501 |
|
|
2017
Q4 | $55K | Hold |
1,817
| – | – | ﹤0.01% | 1467 |
|
|
2017
Q3 | $68K | Hold |
1,817
| – | – | ﹤0.01% | 1457 |
|
|
2017
Q2 | $51K | Hold |
1,817
| – | – | ﹤0.01% | 1520 |
|
|
2017
Q1 | $62K | Buy |
+1,817
| New | +$62K | ﹤0.01% | 1460 |
|
|
2016
Q4 | – | Sell |
-9
| Closed | -$1K | – | 1920 |
|
|
2016
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 1505 |
|
|
2016
Q2 | $1K | Sell |
9
-16
| -64% | -$1.78K | ﹤0.01% | 1525 |
|
|
2016
Q1 | $1K | Buy |
25
+16
| +178% | +$640 | ﹤0.01% | 1524 |
|
|
2015
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 1531 |
|